InVivoMAb Anti-Human IL8/CXCL8 (Iv0023) - HY554010

InVivoMAb Anti-Human IL8/CXCL8 (Iv0023)

Sizes: 50μg, 100μg, 1mg

Catalogue Numbers: HY554010-50, HY554010-100, HY554010-1000

Citations, Manuals and MSDS Available upon request.

Host species: Mouse

Isotype: IgG1, kappa

Species reactivity: Human

Form: Liquid

Storage buffer: 0.01M PBS, pH 7.4.

Concentration: 2.22 mg/ml

Purity: >95% as determined by SDS-PAGE.

Clonality: Monoclonal

Applications: ELISA, FCM, Neutralization

Target: GCP/IL-8 protein II, MDNCF, IL8/NAP1 form III, IL-8(1-77), Neutrophil-activating factor, GCP/IL-8 protein I, GCP/IL-8 protein VI, Interleukin-8, Chemokine (C-X-C motif) ligand 8, Neutrophil-activating protein 1, Monocyte-derived neutrophil chemotactic factor, (Ser-IL-8)72, MDNCF-b, LYNAP, GCP/IL-8 protein V, IL8/NAP1 form IV, MONAP, IL8/NAP1 form V, IL8/NAP1 form VI, NAP-1, Granulocyte chemotactic protein 1, GCP/IL-8 protein III, IL8/NAP1 form II, IL8, IL-8, CXCL8, IL8/NAP1 form I, (Ala-IL-8)77, Protein 3-10C, GCP/IL-8 protein IV, Emoctakin, GCP-1, C-X-C motif chemokine 8, NAF, T-cell chemotactic factor, MDNCF-c, Monocyte-derived neutrophil-activating peptide, Lymphocyte-derived neutrophil-activating factor

Purification: Protein A/G purified from cell culture supernatant.

Stability and Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

For research use only. Not suitable for clinical or therapeutic use.